Erratum to "Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia" [Leuk. Res. 31 (2007) 493-496] (DOI:10.1016/j.leukres.2006.06.024);Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia

Leukemia Research

Volumn 31, Issue 4, 2007, Pages 493-496

  Yetgin, Sevgi ^a   Tavil, Betül ^a   Aytac, Selin ^a   Kuskonmaz, Baris ^a   Karna, Güler ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Hepatitis B vaccination; Leukemia

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBODY RESPONSE; ARTICLE; CANCER CHEMOTHERAPY; CHILD; FEMALE; HEPATITIS B; HUMAN; INCIDENCE; INFECTION RATE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION;

EID: 33846668995     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.05.009     Document Type: Erratum

References (16)

1. Ridgway D., and Wolff L.J. Active immunization of children with leukemia and other malignancies. Leuk Lymphoma 9 (1993) 177-192
2. Berberoglu S., Buyukpamukcu M., Sarialioglu F., Akyuz C., and Ilhan I. Hepatitis B vaccination in children with cancer. Pediatr Hematol Oncol 12 (1995) 171-178
3. Goyal S., Pai S.K., Kelkar R., and Advani S.H. Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk Res 22 (1998) 193-195
4. Somjee S., Pai S., Kelkar R., and Advani S. Hepatitis B vaccination in children with acute lymphoblastic leukemia: results of an intensified immunization schedule. Leuk Res 23 (1999) 365-367
5. Meral A., Sevinir B., and Gunay U. Efficacy of immunization against hepatitis B virus infection in children with cancer. Med Pediatr Oncol 35 (2000) 47-51
6. Hovi L., Valle M., Siimes M.A., et al. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J 14 (1995) 931-935
7. Boguslawska-Jaworska J., Gorczynska E., Seyfried H., Gladysz A., and Zalewska M. Passive and active anti-hepatitis B immunization of children with hematological malignancies. Haematol Blood Transfus 30 (1987) 530-534
8. Fioredda F., Plebani A., Hanau G., Haupt R., Giacchino M., Barisone E., et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy. Eur J Haematol 74 (2005) 20-23
9. Ek T., Mellander L., Andersson B., and Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 22 (2004) [Epub ahead of print]
10. Ek T., Mellander L., Hahn-Zoric M., and Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol 26 (2004) 727-734
11. Somjee S., Pai S., Parikh P., Banavali S., Kelkar R., and Advani S. Passive active prophylaxis against Hepatitis B in children with acute lymphoblastic leukemia. Leuk Res 26 (2002) 989-992
12. Yetgin S., Tunc B., Koc A., Toksoy H.B., Ceyhan M., and Kanra G. Two booster dose hepatitis B virus vaccination in patients with leukemia. Leuk Res 25 (2001) 647-649
13. Haining W.N., Evans J.W., Seth N.P., Callaway G.D., Wucherpfennig K.W., Nadler L.M., et al. Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation. Br J Haematol 127 (2004) 322-325
14. Haining W.N., Neuberg D.S., Keczkemethy H.L., Evans J.W., Rivoli S., Gelman R., et al. Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia. Blood 106 (2005) 1749-1754
15. Brodtman D.H., Rosenthal D.W., Redner A., Lanzkowsky P., and Bonagura V.R. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr 146 (2005) 654-661
16. Smith S., Schiffman G., Karayalcin G., and Bonagura V. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy. J Pediatr 127 (1995) 68-75